Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
TACI/TNFRSF13B/CVID Antibody (165604), FITC, Novus Biologicals™
Mouse Monoclonal Antibody
Supplier: Novus Biologicals FAB1741F
Description
TACI/TNFRSF13B/CVID Monoclonal antibody specifically detects TACI/TNFRSF13B/CVID in Human samples. It is validated for Flow Cytometry, Blocking Assay, CyTOFSpecifications
TACI/TNFRSF13B/CVID | |
Monoclonal | |
FITC | |
PBS | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
Primary | |
Human | |
Purified |
Flow Cytometry, Blocking Assay, CyTOF | |
165604 | |
Flow Cytometry, Blockade of Receptor-ligand Interaction, CyTOF-ready | |
CD267, CD267 antigen, CVID, CVID2, FLJ39942, MGC133214, TACIMGC39952, TNFRSF14B, Transmembrane activator and CAML interactor, tumor necrosis factor receptor 13B, tumor necrosis factor receptor superfamily member 13B, tumor necrosis factor receptor superfamily, member 13B | |
Mouse myeloma cell line NS0-derived recombinant human TACI/TNFRSF13B, Ser2-Thr166, Accession # O14836 | |
0.5 mL | |
Apoptosis, B Cell Development and Differentiation Markers, Signal Transduction | |
23495 | |
Store at 4C in the dark. | |
IgG1 |
Provide Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction